The Cancer Terminator: Our Immune System

Publish Time:2018-11-17

Session 2a: The Cancer Terminator: Our Immune System

10:30 - 10:35 Opening Remark

  • James Ding, General Partner and Managing Director, GSR Venture, LLP; Member, Council of the Future Forum

10:35 - 11:05 Keynote Speech

Conceptual and practical advances in cancer immunotherapy

  • Lieping Chen, UTC Professor in Cancer Research; Professor of Immunobiology, Medicine and Dermatology; Director, Cancer Immunology Program, Yale University School of Medicine; Member, Academia Sinica

11:05 - 11:35 Keynote Speech

Six steps of immune response

  • Yongjun Liu, Global Head of Research, Sanofi; Member, Science Committee of the Future Science Prize

11:35 - 12:30 Panel


  • Charlene Liao, PhD, President and CEO of Immune-Onc Therapeutics, Inc.


  • Lieping Chen (see above)
  • Jiuwei Cui, Director, Cancer Center, the First Hospital of Jilin University 
  • Yang-Xin Fu, Professor of Pathology, University of Texas, Southwestern Medical Center; Mary Nell and Ralph B. Rogers Professorship in Immunology
  • Yongjun Liu (see above)

Yuting Ma, Researcher, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences; PhD supervisor in Peking Union Medical College


Login +